NEWS UPDATES
Aurobindo Pharma
-European arm to buy Actavis’ commercial operations in 7 European nations
-European arm to buy 7 European operations from Actavis for € 30 million
-Actavis deal gives readymade hospital sales infrastructure
-European arm to fund Actavis’ European operations buy via accruals
-European arm to sign commercial, supply deal with Actavis
-Actavis operations’ 2013 sales estimated to be around € 320 million
Karnataka High Court
-Refuses to quash criminal proceedings against Vijay Mallya, Kingfisher Airlines
-Dismisses Kingfisher Airlines, Mallya petition seeking quashing of proceedings
-I-T Department moved under Section 276 (
for non-remittance of TDS
-Non-remittance of TDS for 3 assessment years (2009-12)
-Summons were issued to Vijay Mallya & Kingfisher Airlines
Biocon introduces world’s first biosimilar Trastuzumab
-Trastuzumab is a drug used for breast cancer treatment Biocon says
-Biosimilar drug CANMAb to be used for treating breast cancer in India
-CANMAb jointly developed by company & Mylan under global partnership
-Drug will be available in India by first week of February
Indoco Remedies
-Denies getting any USFDA warning letter
-Indoco Remedies ended trade on Friday down 20 percent on US FDA warning letter reports
Oil Minister
-LPG subsidy to be increased from 9 to 12 cylinders
-Hike in LPG cap to be approved by cabinet soon
JSW Holdings says
-RBI cancels company’s non-banking finance company (NBFC) certificate
-Had applied to RBI for voluntary NBFC de-registration
-Can function as core invest company without registration
Mahindra & Mahindra
-To observe no production days at automotive plants for 1-3 days
-To observe no production days for 3 days at Chakan plant as well
-To observe no production days for up to 3 days at plants in January 2014
-To observe no production days for aligning production with sales
- NTPC board okays Rs 12,530 crore investment for Daripali project
-TCS plans reusable software platforms
-Reliance MediaWorks board to mull delisting today
- Reliance Communications says Reliance Globalcom appoints Bill Barney as CEO
- Dewan Housing to mull interim dividend today
-Banks to recast Rs 5,000-crore debt of Era Infra Engineering
- Sasken Communications board meets today to consider proposal for payment of special dividend
-Cabinet Committee on Economic Affairs likely to take up Hindustan Zinc residual stake sale today
RESULTS DIGEST
Reliance Industries (RIL) Q3
-Net profit at Rs 5,511 crore versus Rs 5,490 crore (QoQ)
-Net revenue at Rs 1.03 lakh crore versus Rs 1.04 lakh crore (QoQ)
-EBITDA at Rs 7,622 crore versus Rs 7,850 crore (QoQ)
-EBITDA margin at 7.4 percent versus 7.6 percent (QoQ)
Wipro Q3
-IT services revenue at Rs 10,327 crore versus Rs 10,068 crore (QoQ)
-IT services revenue at USD 1,678.4 million versus USD 1,631.1 million (QoQ)
-EBIT at Rs 2,379 crore versus Rs 2,264 crore (QoQ)
-EBIT margin at 23 percent versus 22.5 percent (QoQ)
PTC India Q3
-Net profit at Rs 90.8 crore versus Rs 21.9 crore (YoY)
-Income from operations at Rs 2,613 crore versus Rs 1,878 crore (YoY)
-Other income at Rs 15.4 crore versus Rs 1.2 crore (YoY)
-Rs 4.22 crore of excess provision written back
Tata Sponge Q3
-Net profit at Rs 24.3 crore versus Rs 20.6 crore (YoY)
-Net sales at Rs 193.2 crore versus Rs 196.2 crore (YoY)
Force Motors Q3
-Net loss at Rs 8.3 crore versus profit of Rs 8 crore (YoY)
-Total income at Rs 479.5 crore versus Rs 436.3 crore (YoY)
Unichem Labs Q3
-Net profit at Rs 32 crore versus Rs 30.3 crore (YoY)
-Total income at Rs 265 crore versus Rs 232.6 crore (YoY)
-Exceptional gain of Rs 49 crore
-Declares Rs 4/share interim dividend
Original View
